|
|
|
| Interpretation of 2016 asthma management and prevention guideline |
| HUA Wen, HUANG Huaqiong, SHEN Huahao |
| Department of Respiratory and Critical Care Medicine, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China |
|
|
|
Abstract The revision in 2016 asthma management and prevention guideline includes both the diagnosis of asthma and the control-based asthma management. It points out that asthma is a heterogeneous disease, and the diagnosis of asthma should be based on the characteristic pattern of symptoms and evidence of variable airflow limitation, emphasizing the diagnosis of atypical asthma. Besides, the epidemiology of asthma, assessment of asthma, management severe asthma, special type of asthma and asthma in special populations have been added in this version. The revised guideline provides an important reference for the standardized management of asthma.
|
|
Received: 30 August 2016
Published: 25 September 2016
|
|
|
《支气管哮喘防治指南(2016年版)》解读
我国《支气管哮喘防治指南（2016年版）》重点更新和修订了哮喘的诊断和慢性持续期的规范化治疗两大方面内容。哮喘是一种异质性疾病，新版指南强调了肺功能在哮喘诊断中的作用，提出重视不典型哮喘的诊治，并新增哮喘流行病学、哮喘的评估、重症哮喘的规范诊治、特殊类型哮喘及哮喘的某些特殊问题等四方面内容，为哮喘规范化诊治提供了重要的参考。
关键词：
哮喘/诊断,
哮喘/病因学,
哮喘/治疗,
呼吸功能试验,
支气管激发试验,
慢性病,
指南
|
|
| [[1]] |
中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(2016年版)[J].中华结核和呼吸杂志, 2016, 39(9):675-697.Asthma Study Group of Chinese Thoracic Society.2016 asthma management and prevention guidelines[J].Chinese Journal of Tuberculosis and Respiratory Diseases, 2016, 39(9):675-697.(in Chinese)
|
|
|
| [[2]] |
中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗和管理方案)[J].中华结核和呼吸杂志, 2008, 31(3):177-185.Asthma Study Group of Chinese Thoracic Society.Chinese guideline for asthma prevention and management:definition, diagnosis, treatment and management[J].Chinese Journal of Tuberculosis and Respiratory Diseases, 2008, 31(3):177-185.(in Chinese)
|
|
|
| [[3]] |
Global Initiative for Asthma.Global strategy for asthma management and prevention (2015 update)[S].2015.
|
|
|
| [[4]] |
BATEMAN E D, HURD S S, BARNES P J, et al.Global strategy for asthma management and prevention:GINA executive summary[J].Eur Respir J, 2008, 31(1):143-178.
|
|
|
| [[5]] |
苏楠, 林江涛, 刘国梁, 等.我国8省市支气管哮喘患者控制水平的流行病学调查[J].中华内科杂志, 2014, 53(8):601-606.SU Na, LIN Jiangtao, LIU Guoliang, et al.An epidemiological survey of current asthma control status in China[J].Chinese Journal of Internal Medicine, 2014, 53(8):601-606.(in Chinese)
|
|
|
| [[6]] |
林耀广, 王辰, 林江涛, 等.北京地区职业人群支气管哮喘及其相关病症的患病率调查[J].中华结核和呼吸杂志, 2002, 25(11):650-654.LIN Yaoguang, WANG Chen, LIN Jiangtao, et al.Epidemiological survey of the incidence of bronchial asthma in occupations in Beijing area[J].Chinese Journal of Tuberculosis and Respiratory Diseases, 2002, 25(11):650-654.(in Chinese)
|
|
|
| [[7]] |
杭晶卿, 孙碧雄, 戴荷莲, 等.上海浦东金桥地区4万人口支气管哮喘流行病学调查[J].中国实用内科杂志, 2002, 22(10):616-617.HANG Jingqing, SUN Bixiong, DAI Helian, et al.Epidemiological survey of 40 thousand people with bronchial asthma in Jinqiao District of Shanghai, Pudong[J].Chinese Journal of Practical Internal Medicine, 2002, 22(10):616-617.(in Chinese)
|
|
|
| [[8]] |
WONG G W, KWON N, HONG J G, et al.Pediatric asthma control in Asia:phase 2 of the Asthma Insights and Reality in Asia-Pacific (AIRIAP 2) survey[J].Allergy, 2013, 68(4):524-530.
|
|
|
| [[9]] |
SU N, LIN J, CHEN P, et al.Evaluation of asthma control and patient's perception of asthma:findings and analysis of a nationwide questionnaire-based survey in China[J].J Asthma, 2013, 50(8):861-870.
|
|
|
| [[10]] |
CORRAO W M, BRAMAN S S, IRWIN R S.Chronic cough as the sole presenting manifestation of bronchial asthma[J].N Engl J Med, 1979, 300(12):633-637.
|
|
|
| [[11]] |
ZHONG N S, CHEN R C, YANG M O, et al.Is asymptomatic bronchial hyperresponsiveness an indication of potential asthma?A two-year follow-up of young students with bronchial hyperresponsiveness[J].Chest, 1992, 102(4):1104-1109.
|
|
|
| [[12]] |
SHEN H, HUA W, WANG P, et al.A new phenotype of asthma:chest tightness as the sole presenting manifestation[J].Ann Allergy Asthma Immunol, 2013, 111(3):226-227.
|
|
|
| [[13]] |
LOUGHEED M D, LENIERE C, DUCHARME F M, et al.Canadian Thoracic Society 2012 guideline update:diagnosis and management of asthma in preschoolers, children and adults:executive summary[J].Can Respir J, 2012, 19(6):e81-e88.
|
|
|
| [[14]] |
British Thoracic Society, Scottish Intercollegiate Guidelines Network.SIGN 141 British guideline on the management of asthma[S].2014.
|
|
|
| [[15]] |
Global Initiative for Asthma.Global strategy for asthma management and prevention 2014(revision)[S].2014.
|
|
|
| [[16]] |
Godara H, Hirbe A, Nassif M, et al.Washington manual of medical therapeutics[M].34th ed.Philadelphia:Lippincott Williams&Wilkins, 2014:310-312.
|
|
|
| [[17]] |
Asthma:diagnosis and monitoring of asthma in adults, children and young people[EB/OL].(2015-01)[2016-09-01].https://www.nice.org.uk/guidance/gid-cgwave0640/resources/asthma-diagnosis-and-monitoring-draft-nice-guideline2.
|
|
|
| [[18]] |
HETZEL M R, CLARK T J.Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate[J].Thorax, 1980, 35(10):732-738.
|
|
|
| [[19]] |
KVNZLI N, STUTZ E Z, PERRUCHOUD A P, et al.Peak flow variability in the SAPALDIA study and its validity in screening for asthma-related conditions.The SPALDIA Team[J].Am J Respir Crit Care Med, 1999, 160(2):427-434.
|
|
|
| [[20]] |
REDDEL H K, TAYLOR D R, BATEMAN E D, et al.An official American Thoracic Society/European Respiratory Society statement:asthma control and exacerbations:standardizing endpoints for clinical asthma trials and clinical practice[J].Am J Respir Crit Care Med, 2009, 180(1):59-99.
|
|
|
| [[21]] |
Global Initiative for Asthma.Global strategy for asthma management and prevention 2006[S].2006.
|
|
|
| [[22]] |
PETERS S P, KUNSELMAN S J, ICITOVIC N, et al.Tiotropium bromide step-up therapy for adults with uncontrolled asthma[J].N Engl J Med, 2010, 363(18):1715-1726.
|
|
|
| [[23]] |
RODRIGO G J, NEFFEN H, CASTRO-RODRIGUEZ J A.Efficacy and safety of subcutaneous omalizumab vs placebo as add-on therapy to corticosteroids for children and adults with asthma:a systematic review[J].Chest, 2011, 139(1):28-35.
|
|
|
| [[24]] |
PETSKY H L, CATES C J, LASSERSON T J, et al.A systematic review and meta-analysis:tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils)[J].Thorax, 2012, 67(3):199-208.
|
|
|
| [[25]] |
CHUNG, K F, WENZEL S E, BROZEK J L, et al.International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma[J].Eur Respir J, 2014, 43(2):343-373.
|
|
|
| [[26]] |
沈华浩.哮喘手册[M].3版.北京:人民卫生出版社, 2016:223-226.SHEN Huahao.Handbook of asthma[M].3rd ed.Beijing:People's Health Publishing House Co.LTD, 2016:223-226.(in Chinese)
|
|
|
| [[27]] |
Global Initiative for Chronic Obstructive Lung Disease.Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2014)[S].2014.
|
|
|
| [[28]] |
SKOCZY?SKI S, SEMIK-ORZECH A, SZANECKI W, et al.Perimenstrual asthma as a gynecological and pulmonological clinical problem[J].Adv Clin Exp Med, 2014, 23(4):665-668.
|
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
